On December 17^th, 2010, Clinical Professor Piyasakol Sakolsatayadorn, M.D., President of Mahidol University, signed a contract to cooperate and develop Dengue vaccine set 2 (2010-2014), with Dr. Manit Teeratantikanon, M.D., Director-general of Department of Communicable Disease Control, Ministry of Public Health.

          Mahidol University by the Center for Vaccine Development , Institute of Molecular Biosciences (MB) has an important role for developing pre-clinic vaccine under memorandum of agreement, to produce efficient Dengue vaccine according to the regulations. The vaccine will be used to protect and control diseases, which is supported by policy, budget, and administration by Ministry of Public Health. Moreover, there might be more members in the future, so as to develop vaccine as planned.

          The project has four sub-projects: a project testing vaccine in human in phase 1 and phase 2, a project preparing cohort study, a project developing personnel to do research and develop Dengue vaccine, and a project studying possibility of producing vaccine in industrial level. 

Post Date : December 27^th, 2010

from:http://www.mahidol.ac.th/mueng/news/news_2010_Dengue.htm